It was shown that the metabolic syndrome-related gene guanosine monophosphate synthetase (GMPS) could predict prognosis in pancreatic ductal adenocarcinoma (PDAC) (Cai et al., 2021). The gene discussed is GMPS; the disease is metabolic syndrome.